ask="2.98"
ask_size="1000"
average_daily_volume="281521"
bid="1.22"
bid_size="300"
book_value="0.44"
change="-0.03"
change_from_200_day_moving_average="-0.30"
change_from_50_day_moving_average="-0.26"
change_from_52_week_high="-1.44"
change_From_52_week_low="0.78"
change_in_percent="-1.84%"
close="1.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.10"
ebitda="-24.72M"
eps_estimate_current_year="-1.13"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-1.07"
ex_dividend_date="N/A"
float_shares="21469000"
high="1.69"
high_52_weeks="3.04"
last_trade_date="1/26/2017"
last_trade_price="1.60"
last_trade_size="965"
last_trade_time="4:00pm"
low="1.60"
low_52_weeks="0.82"
market_capitalization="37.52M"
moving_average_200_day="1.90"
moving_average_50_day="1.86"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="6.75"
open="1.61"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-15.59%"
percent_change_from_50_day_moving_average="-13.77%"
percent_change_from_52_week_high="-47.37%"
percent_change_from_52_week_low="+95.10%"
previous_close="1.63"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.74"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="2.98"
stock_exchange="NCM"
symbol="CBAY"
volume="104630"
weeks_range_52="0.82 - 3.04"
